Thanks to the bipartisan efforts of State Sen. Michael Connelly (R-Wheaton) and State Rep. Greg Harris (D-Chicago), terminally-ill patients now only await a Governor’s signature of the Illinois “Right to Try” Act, which passed the Illinois Senate on May 19.
“We are excited that Illinois is one-step closer to providing terminally-ill patients with more access to experimental drugs to help end their debilitating health conditions,” Connelly said. “This legislation was negotiated in good faith by both sides of the aisle and is a great example of what can happen when we leave partisan differences at the door in order to craft good public policy.”
House Bill 1335 would give terminally-ill patients access to clinical-trial, experimental medical treatments and medications. "Right to Try" offers hope to terminally-ill citizens afflicted with HIV, ALS, cancer or a litany of other serious conditions access to experimental treatments.
Typically, the federal Food and Drug Administration (FDA) has a five year trial period for the testing of medical and pharmaceutical products and procedures, which delays treatment for terminally-ill patients.
In recent years, terminally-ill patients have gone to extremes for potential cures to their ailments such as traveling to the Netherlands for Alzheimer's treatments, or France for revolutionary chemo-therapies.
The Arizona-based free market think tank Goldwater Institute describes "right to try" as a means that "gives those who've lost hope, one last chance to win it back."
House Bill 1335 passed with a unanimous vote of 52-0 and it now heads to the desk of Governor Bruce Rauner. Similar legislation, Senate Bill 29 is being sponsored in the House of Representatives by Rep. Harris, where it is awaiting a final vote.